PYCR1 and breast cancer: Moreover, the knockdown of PYCR1 reduced the invasion and migration capabilities of BC cell lines and increased the drug sensitivity of orthotopically injected ER-positive tumors in vivo, thus emphasizing the role of PYCR1 in resistance to chemotherapy [123].